Related Experiment Video
Updated: Jan 16, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
Probiotic-derived extracellular vesicles: a novel weapon against viral infections
Yangqian Shi1, Sihang Li1, Shuo Yang1
1School of Basic Medical Sciences, Beihua University, Jilin, Jilin Province, People's Republic of China.
Abstract:
Viral diseases remain a significant global challenge. Although vaccination is the primary strategy for preventing viral infections, the rapid evolution of viruses and their divergence from existing vaccines limit vaccine efficacy. Therefore, novel and safe alternatives to combat viral infections are urgently needed. Probiotic-derived extracellular vesicles (PEVs), lipid bilayer-enclosed nanoparticles, exhibit potential as safe alternatives to live bacteria for treating viral diseases. These vesicles deliver antiviral molecules through mechanisms such as blocking viral adsorption/invasion and modulating host immune responses. This review systematically summarizes the biological characteristics of PEVs, their antiviral mechanisms, and their potential applications against respiratory, enteric, and enveloped viruses. Additionally, recent advances in engineering strategies, clinical translation challenges, and future directions for PEVs are discussed.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Intralumenal Vesicles and Multivesicular Bodies

